The Valley Desk

Clinical trial reportJCO precision oncologyPublished

Phase II Trial of Afatinib in Patients With EGFR-Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
JCO precision oncology
Published
Subject terms
Humans; Neoplasms; Mutation; Adult; Aged; Aged, 80 and over; Middle Aged; Female; Male; ErbB Receptors; Afatinib
PubMed ID
38986051
PubMed Central ID
PMC13371943
Added to directory
Source checked

Report a correction or request removal